Illinois Retina Associates

Two-Year Outcomes of the Ranibizumab for Edema of the mAcula in Diabetes (READ-2) Study

Quan Dong Nguyen, Syed Mahmood Shah, Afsheen Khwaja et al. · Ophthalmology · 2010 · 529 citations

Metabolic Syndrome, Diabetes Management, Diabetes +4

Efficacy and safety of avacincaptad pegol in patients with geographic atrophy (GATHER2): 12-month results from a randomised, double-masked, phase 3 trial

Arshad M. Khanani, Sunil Patel, Giovanni Staurenghi et al. · The Lancet · 2023 · 263 citations · Full text

Clinical Epidemiology, Clinical Trials, Geographic Atrophy +5

INCIDENCE OF ENDOPHTHALMITIS RELATED TO INTRAVITREAL INJECTION OF BEVACIZUMAB AND RANIBIZUMAB

David R. Fintak, Gaurav K. Shah, Kevin J. Blinder et al. · Retina · 2008 · 214 citations

Visual Acuity Outcomes and Anti–Vascular Endothelial Growth Factor Therapy Intensity in Neovascular Age-Related Macular Degeneration Patients

Thomas A. Ciulla, Rehan M. Hussain, John S. Pollack et al. · Ophthalmology Retina · 2019 · 177 citations · Full text

Fewer Anti-vegf Injections, Ocular Disease, Anti-vegf Injections +15

Real-world Outcomes of Anti–Vascular Endothelial Growth Factor Therapy in Diabetic Macular Edema in the United States

Thomas A. Ciulla, Peter Bracha, John S. Pollack et al. · Ophthalmology Retina · 2018 · 145 citations

Diabetic Retinopathy, Ocular Disease, Cardiovascular Disease +9